Andrew leads all activities for Lundbeck in the UK, a pharmaceutical company whose focus is solely on the therapy areas associated with the brain and whose mission is to make every day a better day for people living with brain diseases.

After graduating from the University of Nottingham, Andrew entered the pharmaceutical industry and for nearly 20 years has focussed predominately in the areas of Psychiatry and Neurology in a variety of commercial and leadership roles, helping to ensure patients get access to medicines they need.